Clinical Trials Sponsored by Assembly Biosciences

Total 1870 results

Chipscreen Biosciences, Ltd.

Completed

Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Neurocrine Biosciences
Takeda

Completed

A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation

Healthy Volunteers

United States
Neurocrine Biosciences
Takeda

Completed

A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy Participants

Healthy Volunteers

United States
Ark Biosciences Inc.

Completed

A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects

Healthy

Sweden
Neurocrine Biosciences
Takeda

Completed

A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia

Stable Schizophrenia

United Kingdom
Liminal BioSciences Ltd.

Terminated

Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

Alström Syndrome

United Kingdom
Leadiant Biosciences, Inc.

Completed

STP206 for the Prevention of Necrotizing Enterocolitis (NEC)

Necrotizing Enterocolitis

United States
Kaligia Biosciences, LLC

Unknown

A Human Clinical Study to Collect Calibration and Performance Data for the RBA-1 and KBS-1

Calibration and Validation of Analyte Testing System

United States
Vedanta Biosciences, Inc.

Completed

First-in-human Study of VE303 in Healthy Adult Volunteers

Healthy Volunteers

United States
Chipscreen Biosciences, Ltd.

Completed

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

Ovarian Cancer

China
Spyryx Biosciences, Inc.

Completed

An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis ((HOPE-1))

Cystic Fibrosis

United Kingdom, Canada, France, Italy, Portugal
Proclara Biosciences, Inc.

Completed

A Study of NPT189 in Healthy Subjects

Amyloidosis

Netherlands
Modern Biosciences Ltd

Completed

Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Georgia, Moldova, Republic of, Romania
Genocea Biosciences, Inc.

Terminated

Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

Genital Herpes | HSV-2 Infection

United States
Selecta Biosciences, Inc.

Completed

Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers

Smoking Cessation

Belgium
Liminal BioSciences Ltd.

Completed

Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome

Diabetes | Inflammation and Fibrosis

United Kingdom
Prothena Biosciences Ltd.

Completed

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Primary Amyloidosis

United States
Calithera Biosciences, Inc

Completed

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Multiple Myeloma | Non-Hodgkin's Lymphoma (NHL) | Waldenstrom's Macroglobulinemia (WM) | Other B-cell NHL Subtypes, Including WM | T-cell NHL

United States
Ark Biosciences Inc.

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

Australia
Prothena Biosciences Limited

Completed

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

Psoriasis

United States
LegoChem Biosciences, Inc

Completed

IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers

Healthy

Korea, Republic of
Cleave Biosciences, Inc.

Terminated

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies (CLC-102)

Lymphoid Hematological Malignancies | Relapsed and Refractory Multiple Myeloma

Canada, United States
Neurocrine Biosciences
Evidera

Unknown

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents (RE-Kinect)

Tardive Dyskinesia

United States
Ardea Biosciences, Inc.

Completed

RDEA3170 Bioavailability Study

Gout

United States
Spyryx Biosciences, Inc.

Completed

A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis

Cystic Fibrosis

Canada
Sagimet Biosciences Inc.

Completed

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Solid Malignant Tumor

United Kingdom, United States
Ardea Biosciences, Inc.

Completed

Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence

Healthy

United States
Liminal BioSciences Ltd.

Completed

Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome

Metabolic Syndrome | Type 2 Diabetes

Canada
Ardea Biosciences, Inc.

Completed

Allopurinol Combination Study (RDEA594-203)

Gout

Poland, United States, Spain, Canada, Ukraine, United Kingdom
Calithera Biosciences, Inc

Completed

A Comparative, Pharmacokinetic Study of CB-839 Capsule and Tablet Formulations in Healthy Adults

Healthy Volunteers

United States
Ardea Biosciences, Inc.

Completed

Combining Lesinurad With Allopurinol in Inadequate Responders (CLEAR 1)

Gout

United States
Ardea Biosciences, Inc.

Completed

Combining Lesinurad With Allopurinol in Inadequate Responders (CLEAR 2)

Gout

United States, Germany, New Zealand, South Africa, Spain, Canada, Switzerland, Australia, Belgium, Poland, Ukraine
Prothena Biosciences Limited

Completed

Single Ascending Dose Study of PRX003 in Healthy Subjects

Psoriasis

United States
Lophius Biosciences GmbH

Completed

Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients (CMValue)

Kidney Transplantation | Cytomegalovirus | CMV Specific Immune Response

Germany
Lophius Biosciences GmbH

Completed

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Renal Failure Chronic Requiring Dialysis
Coronado Biosciences, Inc.

Terminated

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder

Autism

United States
Ark Biosciences Inc.

Completed

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Respiratory Syncytial Virus Infections

Australia
Cellectar Biosciences, Inc.

Completed

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

Cancer

United States
BioAxone BioSciences, Inc.

Withdrawn

Cethrin in Acute Cervical Spinal Cord Injury

Spinal Cord Injury
LegoChem Biosciences, Inc

Completed

A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study

Healthy

Korea, Republic of
Ardea Biosciences, Inc.

Completed

Lesinurad Tablet Bioequivalence

Healthy

United States
Ardea Biosciences, Inc.

Completed

Allopurinol Outcome Study (LASSO)

Gout

United States, South Africa, Canada, Belgium, New Zealand, Australia, Germany
Ardea Biosciences, Inc.

Completed

A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout

Hyperuricemia

Canada
Ardea Biosciences, Inc.

Completed

Naïve HIV POC Monotherapy Trial

HIV Infections

Germany, United Kingdom
Ventrus Biosciences, Inc

Terminated

Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids (VEN309)

Internal Hemorrhoids

United States
Cortice Biosciences, Inc.

Terminated

A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
CeloNova BioSciences, Inc.

Completed

REVEAL Study: Vessel Healing After Angioplasty (REVEAL)

Coronary Artery Disease

Italy
Ardea Biosciences, Inc.

Completed

RDEA3170 AME Study

Healthy

United States
Ardea Biosciences, Inc.

Completed

RDEA3170 and Febuxostat Drug Interaction Study

Healthy

United States
Ventrus Biosciences, Inc

Unknown

A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design

Skin Irritation

United States

Clinical Trials Sponsored by Assembly Biosciences

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations